top of page
Insights That Move the GPCR Field Forward
Read the latest analyses, interviews, and discoveries shaping the GPCR ecosystem — from research breakthroughs to biotech strategy.
Blog: Blog2
Search
Carola Weiss joins InterAx Biotech AG as VP Business Development
February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined the company as VP Business...

GPCR News
Jan 31, 20221 min read
Sosei Heptares reported its FY2021 financial result and provided an update on operational activities
February 2022 Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR News
Jan 31, 20221 min read
Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...
February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with pioneer as co-founder "Jan 27,...

GPCR News
Jan 31, 20221 min read


Dr. Juan José Fung - Dr. GPCR Podcast
Mark your calendars! The Dr. GPCR Podcast is back this week with a brand new episode. Our guest is none other than Dr. Juan Jose Fung,...

Dr. GPCR News
Jan 21, 20221 min read


Mark Schmeizl - Dr. GPCR Podcast
Episode 55 of the Dr. GPCR podcast is now available! Our guest is Mark Schmeizl! He is a pro at Matchmaking the top talent in the life...

Dr. GPCR News
Jan 6, 20221 min read
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
January 2022 Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered...

GPCR News
Jan 1, 20221 min read
Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia
January 2022 "Watch our CEO Tim Dyer on AlphaStreet. In his interview, Mr. Dyer provides an overview of our #allostericmodulator...

GPCR News
Jan 1, 20221 min read
Novo Nordisk moves to strengthen obesity efforts
January 2022 "After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position in the obesity space through a...

GPCR News
Jan 1, 20221 min read
ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
January 2022 ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis "SAN CARLOS,...

GPCR News
Jan 1, 20221 min read
Learn more about Neurocrine Biosciences with their new video
January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special. It...

GPCR News
Jan 1, 20221 min read
Verily links up with Sosei Heptares for GPCR drug discovery
January 2022 "G-protein-coupled receptors’ star has been on the rise in biotech in recent years as researchers have discovered the vast...

GPCR News
Jan 1, 20221 min read
ShouTi Pharma has a brand new website
January 2022 "We are an experienced, innovative, global team on a bold mission to improve health by creating and developing life-changing...

GPCR News
Jan 1, 20221 min read
Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and...
January 2022 Inversago Pharma Completes Phase 1 Clinical Trial on First-in-Class, Peripheral CB1 Blocker and Provides Strategy Update...

GPCR News
Jan 1, 20221 min read
Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
January 2022 "OXFORD, England--Professor Charlotte Deane, Ph.D., of the University of Oxford, has joined Exscientia as Chief Scientist of...

GPCR News
Jan 1, 20221 min read
Drug Discovery Picks Up the Pace, Stays on Target
January 2022 "Voltaire argued, “Perfection is attained by slow degrees; it requires the hand of time.” However, in drug discovery...

GPCR News
Jan 1, 20221 min read
Learn more about Neurocrine Biosciences with their new video
January 2022 "The Neurocrine Biosciences story puts into words what makes the work and people at Neurocrine Biosciences so special. It...

GPCR News
Dec 31, 20211 min read


Dr. Nicola J. Smith - Dr. GPCR Podcast
Next on the Dr. GPCR Podcast, we have Dr. Nicola Smith, Molecular Pharmacologist, lab head, and senior lecturer at UNSW Sydney. Subscribe...

Dr. GPCR News
Dec 27, 20211 min read
Targeted Therapies to Reduce Side Effects in Modern Drug Development
December 2021 "Drug development is rarely trivial. In fact, it is often costly, frustrating, and tortuous—and more often than not it...

GPCR News
Dec 1, 20211 min read
Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
December 2021 "Dame Carol Robinson DBE, FRS, FRSC, FMedSci, Oxford University’s first female Professor of Chemistry, former president of...

GPCR News
Dec 1, 20211 min read
Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research
December 2021 "Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research. Peter joined Tectonic to help chart new territory in GPCR...

GPCR News
Dec 1, 20211 min read
Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
December 2021 "Tokyo, Japan and Cambridge, UK, 24 December 2021 – Sosei Group Corporation (“Sosei Heptares”; TSE: 4565) today announces...

GPCR News
Dec 1, 20211 min read
Addex Raises $10 Million In Equity Financing
December 2021 "Geneva, Switzerland, December 17, 2021 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...

GPCR News
Nov 30, 20211 min read
Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
December 2021 "3-part randomized, double-blind, placebo-controlled Phase 1 study will evaluate TRV045 safety, tolerability, and PK in...

GPCR News
Nov 30, 20211 min read
Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
December 2021 Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the...

GPCR News
Nov 30, 20211 min read
bottom of page

